Opiumism High Impact Factor Journals
Habitual opium use is known as opiumism. Opium obtained from Opium Poppy is used by mankind medicinally and recreationally. It is used medically to alleviate pain. Smoking is the most common and safe method of opium use. It gives rise to euphoria, nausea, sleepiness, a warm, fuzzy feeling and peace. It exhibits signs of many unpleasant symptoms upon withdrawal. High-impact publications are those which are considered highly important in their fields. Article
impact factor provides a quantitative assessment method for the ranking, review, selection, and comparison of related papers. It represents the average number of citations to recent papers published in science and
social science journals in a given year or time, and is often used as a measure for a journal's relative importance within its field. It is first devised by the Institute for Scientific
Information founder, Eugene Garfield.
High Impact List of Articles
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
A retrospective study of Spondylodiscitis with clinical, imaging and therapeutic correlations
Barbara Brogna*, Alessandra Coppola, Elio Bignardi
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Amantadine and phenytoin: patent protected cases of drug repositioning
Jan M. Keppel Hesselink
Research Article: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Changing the paradigm: circulating tumor DNA as a liquid biopsy for clinical biomarker assessments
Timothy R Wilson & Mark R Lackner
Clinical Trail Methodology: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
-
Antibiotic treatment of acute otitis media in children: to wait or not to wait?
Eugene Leibovitz
Editorial: Clinical Investigation
Relevant Topics in Clinical